参考资料:
[1]http://www.cell.com/cell/fulltext/S0092-8674(17)31143-1
[2] Liu, Y., Zeng, Y., Liu, L., Zhuang, C., Fu, X., Huang, W., and Cai, Z. (2014). Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells. Nat. Commun. 5, 5393.
[3] Klebanoff, C.A., Rosenberg, S.A., and Restifo, N.P. (2016). Prospects for gene-engineered T cell immunotherapy for solid cancers. Nat. Med. 22, 26–36.
[4]Lasek, W., Zagozd_ zon, R., and Jakobisiak, M. (2014). Interleukin 12: still a _
promising candidate for tumor immunotherapy? Cancer Immunol. Immunother.
63, 419–435.
[5]Lengyel, E., Burdette, J.E., Kenny, H.A., Matei, D., Pilrose, J., Haluska, P.,
Nephew, K.P., Hales, D.B., and Stack, M.S. (2014). Epithelial ovarian cancer
experimental models. Oncogene 33, 3619–3633.